“IMMUNE CHECKPOINT INHIBITORS IN SOLID TUMORS: MECHANISMS, CLINICAL EFFICACY, BIOMARKER-GUIDED PATIENT SELECTION, AND IMMUNE-RELATED ADVERSE EVENTS” (2026) Journal of Multidisciplinary Sciences and Innovations, 5(03), pp. 1709–1714. doi:10.55640/.